Inovio Pharmaceuticals Short Interest Ratio and Short Volume

Inovio Pharmaceuticals (NASDAQ:INO) Short Interest Frequently Asked Questions

What is Inovio Pharmaceuticals' current short interest?

Short interest is the volume of Inovio Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 46,000,000 shares of INO short. 22.23% of Inovio Pharmaceuticals' shares are currently sold short. Learn More on Inovio Pharmaceuticals' current short interest.

What is a good short interest ratio for Inovio Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Inovio Pharmaceuticals currently has a short interest ratio of 11.0. Learn More on a good short interest ratio for Inovio Pharmaceuticals

Which institutional investors are shorting Inovio Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inovio Pharmaceuticals: Pathstone Family Office LLC, Jefferies Group LLC, Walleye Trading LLC, Pathstone Family Office LLC, Aristides Capital LLC, Citadel Advisors LLC, Bank of America Corp DE, Jefferies Group LLC, Simplex Trading LLC, Bank of Montreal Can, HAP Trading LLC, Susquehanna International Group LLP, Wolverine Trading LLC, IMC Chicago LLC, and Cutler Group LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Inovio Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.23% of Inovio Pharmaceuticals' floating shares are currently sold short.

Is Inovio Pharmaceuticals' short interest increasing or decreasing?

Inovio Pharmaceuticals saw a increase in short interest in October. As of October 15th, there was short interest totaling 46,000,000 shares, an increase of 1.7% from the previous total of 45,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Inovio Pharmaceuticals' float size?

Inovio Pharmaceuticals currently has issued a total of 210,357,000 shares. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inovio Pharmaceuticals currently has a public float of 206,890,000 shares.

How does Inovio Pharmaceuticals' short interest compare to its competitors?

22.23% of Inovio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Inovio Pharmaceuticals: ICU Medical, Inc. (2.40%), Inari Medical, Inc. (4.50%), Nevro Corp. (7.23%), Merit Medical Systems, Inc. (2.85%), Haemonetics Co. (3.80%), AtriCure, Inc. (2.17%), Axonics, Inc. (12.71%), The Beauty Health Company (20.00%), NuVasive, Inc. (7.82%), and Silk Road Medical, Inc (6.61%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.75 billion), S&P Global Inc. ($7.73 billion), Charter Communications, Inc. ($5.40 billion), Snowflake Inc. ($4.50 billion), Canadian Pacific Railway Limited ($4.39 billion), Uber Technologies, Inc. ($4.21 billion), Wayfair Inc. ($4.15 billion), Palo Alto Networks, Inc. ($3.27 billion), Teladoc Health, Inc. ($2.78 billion), and DoorDash, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Inovio Pharmaceuticals stock?

Short selling INO is an investing strategy that aims to generate trading profit from Inovio Pharmaceuticals as its price is falling. Inovio Pharmaceuticals' stock is trading down $0.05 today. To short Inovio Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Inovio Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inovio Pharmaceuticals?

A short squeeze for Inovio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INO, which in turn drives the price of the stock up even further.

How often is Inovio Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INO, twice per month. The most recent reporting period available is October, 15 2021.